Get startedLog in
    Picture of LakeShore Biopharma Co logo

    LSBCF — LakeShore Biopharma Co News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapValue Trap
    All News

    Brief: Ys Biopharma Announces Record Vaccine Revenues And Preliminary Financial Results For Fy2023 Ended March 31, 2023

    Picture of LakeShore Biopharma Co logoLakeShore Biopharma Co
    18/04/2023 12:03
    April 18 (Reuters) - YS BIOPHARMA  YS.O :
    * YS BIOPHARMA ANNOUNCES RECORD VACCINE REVENUES AND
PRELIMINARY
FINANCIAL RESULTS FOR FY2023 ENDED MARCH 31, 2023
    * YS BIOPHARMA - SEES FY 2023 TOTAL REVENUE OF APPROXIMATELY
$103
MILLION, REPRESENTING YEAR-OVER-YEAR GROWTH OF 30%

Source text for Eikon:  ID:nPn85H7LGa 
Further company coverage:  YS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on LakeShore Biopharma Co

    See all news